Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+5.97%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$10.8B
AUM Growth
-$573M
(-5%)
Cap. Flow
-$872M
Cap. Flow
% of AUM
-8.04%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
577
New
157
Increased
112
Reduced
119
Closed
154
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$148M |
| 2 |
Skyworks Solutions
SWKS
|
+$122M |
| 3 |
Equitable Holdings
EQH
|
+$115M |
| 4 |
Target
TGT
|
+$113M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$109M |
Top Sells
| 1 |
IBM
IBM
|
+$155M |
| 2 |
NXP Semiconductors
NXPI
|
+$138M |
| 3 |
Salesforce
CRM
|
+$132M |
| 4 |
PF
Pinnacle Foods, Inc.
PF
|
+$120M |
| 5 |
Akamai
AKAM
|
+$114M |
Sector Composition
| 1 | Technology | 19.87% |
| 2 | Industrials | 16.28% |
| 3 | Energy | 11.93% |
| 4 | Financials | 11.89% |
| 5 | Healthcare | 11.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBIO
376
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $759K | 0.01% |
+60,000
| New | +$759K |
|
377
Lam Research
LRCX
$133B
| $757K | 0.01% |
43,810
-67,460
| -61% | -$1.17M |
|
378
Qualigen Therapeutics
QLGN
$2.93M
| $753K | 0.01% |
23
-12
| -34% | -$393K |
|
|
TCDA
379
DELISTED
Tricida, Inc. Common Stock
TCDA
| $748K | 0.01% |
+25,000
| New | +$748K |
|
380
Eagle Materials
EXP
$7.71B
| $741K | 0.01% |
7,059
-3,124
| -31% | -$328K |
|
|
CFMS
381
DELISTED
Conformis, Inc. Common Stock
CFMS
| $728K | 0.01% |
23,286
-12,393
| -35% | -$387K |
|
|
FSTX
382
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $706K | 0.01% |
14,884
-38,595
| -72% | -$1.83M |
|
383
Minerva Neurosciences
NERV
$15.2M
| $692K | 0.01% |
10,483
+335
| +3% | +$22.1K |
|
|
PETX
384
DELISTED
Aratana Therapeutics, Inc.
PETX
| $584K | 0.01% |
+137,345
| New | +$584K |
|
385
Ardelyx
ARDX
$1.59B
| $543K | ﹤0.01% |
+146,666
| New | +$543K |
|
|
ATYR
386
aTyr Pharma
ATYR
$520M
| $521K | ﹤0.01% |
40,892
-8,982
| -18% | -$114K |
|
387
Incyte
INCY
$16.9B
| $490K | ﹤0.01% |
7,311
-244,165
| -97% | -$16.4M |
|
388
Cidara Therapeutics
CDTX
$1.58B
| $481K | ﹤0.01% |
4,628
-212
| -4% | -$22K |
|
389
Cardlytics
CDLX
$48.5M
| $478K | ﹤0.01% |
21,988
-130,915
| -86% | -$2.85M |
|
390
Sol-Gel Technologies
SLGL
$76.7M
| $474K | ﹤0.01% |
6,143
+197
| +3% | +$15.2K |
|
|
SNNA
391
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| $421K | ﹤0.01% |
27,730
-22,724
| -45% | -$345K |
|
392
XWELL
XWEL
$6.27M
| $406K | ﹤0.01% |
1,159
-91
| -7% | -$31.9K |
|
|
VRML
393
DELISTED
Vermillion, Inc.
VRML
| $383K | ﹤0.01% |
+490,091
| New | +$383K |
|
|
EGLT
394
DELISTED
Egalet Corporation
EGLT
| $364K | ﹤0.01% |
862,459
+27,579
| +3% | +$11.6K |
|
|
ATTO
395
DELISTED
Atento S.A.
ATTO
| $292K | ﹤0.01% |
8,489
-231,250
| -96% | -$7.95M |
|
|
AFSI
396
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $281K | ﹤0.01% |
+19,300
| New | +$281K |
|
|
TCON
397
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $270K | ﹤0.01% |
500
+16
| +3% | +$8.64K |
|
|
KA
398
DELISTED
Kineta, Inc. Common Stock
KA
| $213K | ﹤0.01% |
545
-26
| -5% | -$10.2K |
|
399
Zai Lab
ZLAB
$3.5B
| $204K | ﹤0.01% |
8,760
-5,214
| -37% | -$121K |
|
|
YOGA
400
DELISTED
YogaWorks, Inc. Common Stock
YOGA
| $76K | ﹤0.01% |
42,275
-253,856
| -86% | -$456K |
|